Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors

Gamo, Nao J.; Wang, Min; Arnsten, Amy F.T.

doi:10.1016/j.jaac.2010.06.015

Cited by 232Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors

Open access

Gamo, Nao J., Wang, Min, Arnsten, Amy F.T.·2010·Journal of the American Academy of Child & Adolescent Psychiatry

DOI 10.1016/j.jaac.2010.06.015PMC PMC2999884

Open this paper in CoChat — free account

Abstract

Objective This study examined the effects of the attention-deficit/hyperactivity disorder treatments, methylphenidate (MPH) and atomoxetine (ATM), on prefrontal cortex (PFC) function in monkeys and explored the receptor mechanisms underlying enhancement of PFC function at the behavioral and cellular levels.Method Monkeys performed a working memory task after administration of a wide range of MPH or ATM doses. The optimal doses were challenged with the α(2)-adrenoceptor antagonist, idazoxan, or the D(1) dopamine receptor antagonist, SCH23390 (SCH). In a parallel physiology study, neurons were recorded from the dorsolateral PFC of a monkey performing a working memory task. ATM, SCH, or the α(2) antagonist, yohimbine, were applied to the neurons by iontophoresis.Results MPH and ATM generally produced inverted-U dose-response curves, with improvement occurring at moderate doses, but not at higher doses. The beneficial effects of these drugs were blocked by idazoxan or SCH. At the cellular level, ATM produced an inverted-U dose-response effect on memory-related firing, enhancing firing for preferred directions (increasing "signals") and decreasing firing for the nonpreferred directions (decreasing "noise"). The increase in persistent firing for the preferred direction was blocked by yohimbine, whereas the suppression of firing for the nonpreferred directions was blocked by SCH.Conclusions Optimal doses of MPH or ATM improved PFC cognitive function in monkeys. These enhancing effects appeared to involve indirect stimulation of α(2) adrenoceptors and D(1) dopamine receptors in the PFC. These receptor actions likely contribute to their therapeutic effects in the treatment of attention-deficit/hyperactivity disorder.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jaac.2010.06.015

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Methylphenidate directly interacts with adrenergic receptors, and through α2 adrenergic receptor activation it stimulates cortical excitability.
“Multiple studies have demonstrated that MPH also directly interacts with adrenergic receptors (109, 115, 119, 120). Through activation of α2 adrenergic receptors, MPH has been demonstrated to stimulate cortical excitability (109).”
From The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities (2018) · cites this paper as [115]
The Conclusions describe MPH’s effects on α2 adrenoceptors as indirect, contrary to the claim of direct receptor interaction. The Discussion says MPH’s cellular actions could not be documented; the reported increase in prefrontal neuronal firing followed α2A receptor stimulation, not a demonstrated effect of MPH on cortical excitability. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Optimal doses of atomoxetine improved working memory performance in monkeys, while higher doses impaired performance.
“Thus, optimal doses improved working memory performance in monkeys, while higher doses impaired performance.”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
The Results (Behavioral Data; page unavailable) report that optimal atomoxetine doses improved spatial working-memory performance in monkeys. The claim overstates the effect of higher doses: the paper says they impaired performance or had no effect, with substantial variation among monkeys. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Stimulants and nonstimulants act to alter the abnormal neural responses in ADHD patients through α2-adrenergic and dopamine D1 receptors to improve cognitive functions through the reactivity of the prefrontal cortex based on its high sensitivity to catecholamines.
“stimulants and nonstimulants act to alter the abnormal neural responses in ADHD patients through α2-adrenergic and dopamine D1 receptors to improve cognitive functions through the reactivity of the prefrontal cortex based on its high sensitivity to catecholamines”
From Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: A comparative neuroimaging analysis (2024) · cites this paper as Gamo, Wang, & Arnsten, 2010
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
The procognitive effects of methylphenidate in a working memory task are blocked by the α2 adrenergic antagonist idazoxan.
“Further evidence for the interaction of MPH with α2 adrenergic receptors comes from data indicating that the procognitive effects of MPH in a working memory task are blocked by the α2 adrenergic antagonist idazoxan (115).”
From The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities (2018) · cites this paper as [115]
The clinical efficacy of NE reuptake inhibitors (e.g., atomoxetine) and α2A-agonists (e.g., guanfacine) in treating ADHD underscores the therapeutic importance of the noradrenergic system.
“The clinical efficacy of NE reuptake inhibitors (e.g., atomoxetine) and α2A-agonists (e.g., guanfacine) in treating ADHD underscores the therapeutic importance of this system”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [69]

These agents produce an inverted U dose response, whereby higher doses can actually impair PFC cognitive performance in monkeys.
“These agents produce an inverted U dose response, whereby higher doses can actually impair PFC cognitive performance in monkeys (Gamo et al., 2010).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
Norepinephrine and dopamine enhance PFC function through actions at postsynaptic α2A-adrenoceptors and dopamine D1-receptors, respectively.
“This article reviews studies in animals showing that norepinephrine and dopamine enhance PFC function through actions at postsynaptic α2A-adrenoceptors and dopamine D1-receptors, respectively.”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
Animal studies have shown that therapeutic doses of methylphenidate and atomoxetine improve PFC function by increasing endogenous norepinephrine stimulation of α2-receptors and dopamine stimulation of D1-receptors in rats and monkeys.
“Animal studies have shown that therapeutic doses of methylphenidate and atomoxetine improve PFC function by increasing endogenous NE stimulation of α2-receptors and DA stimulation of D1-receptors in rats (Arnsten and Dudley, 2005) and monkeys (Gamo et al., 2010).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
An inverted U dose-response was also observed at the neuronal level when atomoxetine was iontophoretically applied onto PFC neurons in monkeys performing a working memory task.
“An inverted U dose-response was also observed at the neuronal level when atomoxetine was iontophoretically applied onto PFC neurons in monkeys performing a working memory task.”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
The enhancing effects of atomoxetine were blocked by co-administration of either a norepinephrine alpha-2 or a dopamine D1 antagonist.
“The enhancing effects were blocked by co-administration of either an NE alpha-2 or DA D1 antagonist (Gamo et al., 2010).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
Lower optimal amounts of atomoxetine enhanced signals via indirectly increasing norepinephrine stimulation of alpha-2A receptors, and/or decreased noise via indirectly increasing dopamine stimulation of D1 receptors.
“Lower “optimal” amounts of atomoxetine enhanced “signals” (neuronal firing during the delay period for the neuron’s preferred direction) via indirectly increasing NE stimulation of alpha-2A receptors, and/or decreased “noise” (neuronal firing for nonpreferred directions) via indirectly increasing DA stimulation of D1 receptors (Gamo et al., 2010).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
Recent studies in monkeys performing a working memory task show that atomoxetine produces an inverted U dose-response, similar to that seen with stimulants.
“Recent studies in monkeys performing a working memory task show that atomoxetine produces an inverted U dose-response, similar to that seen with stimulants (Gamo et al., 2010).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Gamo et al., 2010
The inverted U-shape model of prefrontal cortical dopamine levels and function might also operate in the striatum.
“and indicates that the established inverted U-shape model of prefrontal cortical dopamine levels and function (and consequently neurocognitive performance), might also operate in the striatum.51-53”
From Striatal sensitivity during reward processing in attention-deficit/hyperactivity disorder (2012) · cites this paper as [52]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Stress signalling pathways that impair prefrontal cortex structure and function
Arnsten, A. F. T. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2648 · Cited by 3,299 · see citing works
Self-citation
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663 · see citing works
Basal ganglia and cerebellar loops: motor and cognitive circuits
Middleton, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00040-5 · Cited by 1,940 · see citing works
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · see citing works
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500 · see citing works
Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · see citing works
The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive
Goldman-Rakic, P. S. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0129 · Cited by 1,072 · see citing works
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013 · see citing works
Self-citation
Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845 · see citing works
Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey
Ghashghaei, H. T., & Barbas, H. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00446-3 · Cited by 785 · see citing works
The neural correlates of attention deficit hyperactivity disorder: an ALE meta‐analysis
Dickstein, S. G., Bannon, K., Xavier Castellanos, F., & Milham, M. P. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01671.x · Cited by 745 · see citing works
Structural Brain Imaging of Attention-Deficit/Hyperactivity Disorder
Seidman, L. J., Valera, E. M., & Makris, N. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.019 · Cited by 676 · see citing works
α2A-Adrenoceptors Strengthen Working Memory Networks by Inhibiting cAMP-HCN Channel Signaling in Prefrontal Cortex
Wang, M., Ramos, B. P., Paspalas, C. D., Shu, Y., Simen, A., Duque, A., Vijayraghavan, S., Brennan, A., Dudley, A., Nou, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.015 · Cited by 672 · see citing works
Self-citation
Methylphenidate Preferentially Increases Catecholamine Neurotransmission within the Prefrontal Cortex at Low Doses that Enhance Cognitive Function
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617 · see citing works
Self-citation
Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain
Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-j0004.2000 · Cited by 608 · see citing works
Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter
Sesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., & Levey, A. I. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02697.1998 · Cited by 582 · see citing works
Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD.
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580 · see citing works
Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573 · see citing works
Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys
Arnsten, A. F. T., Cai, J. X., Murphy, B. L., & Goldman-Rakic, P. S. (1994) · Psychopharmacology · doi:10.1007/bf02245056 · Cited by 566 · see citing works
Self-citation
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry
Dalley, J. W., Mar, A. C., Economidou, D., & Robbins, T. W. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.021 · Cited by 467 · see citing works
The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder
Arnsten, A. F. T. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050084013 · Cited by 458 · see citing works
Self-citation
Destruction and Creation of Spatial Tuning by Disinhibition: GABA<sub>A</sub>Blockade of Prefrontal Cortical Neurons Engaged by Working Memory
Rao, S. G., Williams, G. V., & Goldman-Rakic, P. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00485.2000 · Cited by 407 · see citing works
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation
Kehagia, A. A., Murray, G. K., & Robbins, T. W. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.01.007 · Cited by 398 · see citing works
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder
Aron, A. R., Dowson, J. H., Sahakian, B. J., & Robbins, T. W. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00609-7 · Cited by 392 · see citing works
Fundamentals of Attention-Deficit/Hyperactivity Disorder: Circuits and Pathways
Arnsten, A. F. T. (2006) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 380 · see citing works
Self-citation
Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363 · see citing works
Self-citation
Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys
Goldman‐Rakic, P. S., & Brown, R. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90053-1 · Cited by 357 · see citing works
Protein kinase C overactivity impairs prefrontal cortical regulation of working memory
Birnbaum, S. G., Yuan, P. X., Wang, M., Vijayraghavan, S., Bloom, A. K., Davis, D. J., Gobeske, K. T., Sweatt, J. D., Manji, H. K., & Arnsten, A. F. T. (2004) · Science · doi:10.1126/science.1100021 · Cited by 318 · see citing works
Self-citation
Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine
Kuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316 · see citing works
Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study
Chamberlain, S. R., Hampshire, A., Müller, U., Rubia, K., del Campo, N., Craig, K. J., Regenthal, R., Suckling, J., Roiser, J. P., Grant, J. E., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.014 · Cited by 300 · see citing works
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder
Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.003 · Cited by 288 · see citing works
Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set
Crofts, H. S. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.11.1015 · Cited by 284 · see citing works
Differential regulation of fronto-executive function by the monoamines and acetylcholine
Robbins, T., & Roberts, A. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm066 · Cited by 279 · see citing works
Methylphenidate improves working memory and set‐shifting in AD/HD: relationships to baseline memory capacity
Mehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00221.x · Cited by 257 · see citing works
Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression
Miller, G. M., & Madras, B. K. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000921 · Cited by 230 · see citing works
Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
Arnsten, A. F. T. (2006) · PubMed · Cited by 203 · see citing works
Self-citation
Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction
Shansky, R. M., Glavis-Bloom, C., Lerman, D., McRae, P., Benson, C., Miller, K., Cosand, L., Horvath, T. L., & Arnsten, A. F. T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001435 · Cited by 200 · see citing works
Self-citation
Catecholamine and second messenger influences on prefrontal cortical networks of “representational knowledge”: a rational bridge between genetics and the symptoms of mental illness
Arnsten, A. F. T. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm033 · Cited by 200 · see citing works
Self-citation
Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats
Bari, A., Eagle, D. M., Mar, A. C., Robinson, E. S. J., & Robbins, T. W. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1537-0 · Cited by 194 · see citing works
Delayed-response deficit induced by local injection of the α2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys
Li, B.-M., & Mei, Z.-T. (1994) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(05)80034-2 · Cited by 186 · see citing works
Dynamic network connectivity: a new form of neuroplasticity
Arnsten, A. F. T., Paspalas, C. D., Gamo, N. J., Yang, Y., & Wang, M. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.05.003 · Cited by 160 · see citing works
Self-citation
Neurobiology of Attention Deficit Hyperactivity Disorder
Kieling, C., Kieling, R. R., Tannock, R., & Castellanos, F. X. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.012 · Cited by 138 · see citing works
Stimulant Actions in Rodents: Implications for Attention-Deficit/Hyperactivity Disorder Treatment and Potential Substance Abuse
Kuczenski, R. T., & Segal, D. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.036 · Cited by 121 · see citing works
Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT
van Dyck, C. H., Malison, R. T., Seibyl, J. P., Laruelle, M. A., Klumpp, H., Zoghbi, S. S., Baldwin, R. M., & Innis, R. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00152-4 · Cited by 119 · see citing works
The α -2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys
Franowicz, J. S., & Arnsten, A. F. T. (1998) · Psychopharmacology · doi:10.1007/s002130050533 · Cited by 118 · see citing works
Self-citation
The effects of sex and hormonal status on restraint-stress-induced working memory impairment
Shansky, R. M., Rubinow, K., Brennan, A., & Arnsten, A. F. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-8 · Cited by 107 · see citing works
Self-citation
Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity
Miller, G. M., Yatin, S. M., Garza, R. D. L., Goulet, M., & Madras, B. K. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00288-6 · Cited by 106 · see citing works
A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders
Hess, C., Reif, A., Strobel, A., Boreatti-Hümmer, A., Heine, M., Lesch, K.-P., & Jacob, C. P. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0138-0 · Cited by 104 · see citing works
Cellular and subcellular localization of the dopamine transporter in rat cortex
Sesack, S. R., Hawrylak, V. A., Guido, M. A., & Levey, A. I. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60720-6 · Cited by 101 · see citing works
Locomotor hyperactivity induced by blockade of prefrontal cortical α2-adrenoceptors in monkeys
Ma, C.-L., Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.004 · Cited by 96 · see citing works
Self-citation
Differential Contributions of Dopamine and Serotonin to Orbitofrontal Cortex Function in the Marmoset
Walker, S. C., Robbins, T. W., & Roberts, A. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn136 · Cited by 95 · see citing works
Relative lack of cognitive effects of methylphenidate in elderly male volunteers
Clark, L., Aron, A. R., Dowson, J. H., Sahakian, B. J., Turner, D. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1457-3 · Cited by 94 · see citing works
Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder
Kim, B. N., Lee, J. S., Cho, S. C., & Lee, D. S. (2001) · Yonsei Medical Journal · doi:10.3349/ymj.2001.42.1.19 · Cited by 88 · see citing works
Noradrenergic genotype predicts lapses in sustained attention
Greene, C. M., Bellgrove, M. A., Gill, M., & Robertson, I. H. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.10.003 · Cited by 86 · see citing works
Cognitive impairment in aged rhesus monkeys associated with monoamine receptors in the prefrontal cortex
Moore, T. L., Schettler, S. P., Killiany, R., Herndon, J. G., Luebke, J. I., Moss, M. B., & Rosene, D. L. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.12.003 · Cited by 79 · see citing works
The −1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD
Kieling, C., Genro, J. P., Hutz, M. H., & Rohde, L. A. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30636 · Cited by 65 · see citing works
Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder
Mehta, M. A., Calloway, P., & Sahakian, B. J. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400314 · Cited by 63 · see citing works
Variation of variable number of tandem repeat sequences in the 3′-untranslated region of primate dopamine transporter genes that affects reporter gene expression
Inoue‐Murayama, M., Adachi, S., Mishima, N., Mitani, H., Takenaka, O., Terao, K., Hayasaka, I., Ito, S., & Murayama, Y. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01125-4 · Cited by 61 · see citing works
Methylphenidate and cognitive perseveration in hyperactive children
Tannock, R., & Schachar, R. (1992) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1992.tb00940.x · Cited by 59 · see citing works
Adrenergic and serotonergic receptors in aged monkey neocortex
Bigham, M. H., & Lidow, M. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80012-g · Cited by 59 · see citing works
Perseveration induced by methylphenidate in children: preliminary findings
Dyme, I. Z., Sahakian, B. J., Golinko, B. E., & Rabe, E. F. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80177-2 · Cited by 56 · see citing works
Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders
Miller, G. M., Garza, R. D. L., Novak, M. A., & Madras, B. K. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000809 · Cited by 44 · see citing works
5.3 Dopamine’s Influence on Prefrontal Cortical Cognition: Actions and Circuits in Behaving Primates
Arnsten, A. F. T., Vijayraghavan, S., Wang, M., Gamo, N. J., & Paspalas, C. D. (2009) · Dopamine Handbook · doi:10.1093/acprof:oso/9780195373035.003.0016 · Cited by 23 · see citing works
Self-citation
Neurobiology of Attention Regulation and Its Disorders
Arnsten, A. F. T., & Castellanos, F. X. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780195398212.003.0007 · Cited by 15 · see citing works
Self-citation
Attention-Deficit/Hyperactivity Disorder
Spencer, T. J. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.314 · Cited by 14 · see citing works
Noise Stress Impairs Prefrontal Cortical Cognitive Function in Monkeys: Evidence for a Hyperdopaminergic Mechanism
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.362 · Cited by 6 · see citing works
Self-citation

Flagged first, then by citations

2 of the 68 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

[21]Li BM Mei ZT Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys Behav Neural Biol 1994 62 134 139 7993303

Sorted by citations

Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921 · see citing works
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631 · see citing works
Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks
Arnsten, A. F. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.027 · Cited by 493 · see citing works
Self-citation
A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
Sharma, A., & Couture, J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013510699 · Cited by 516 · see citing works
Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders
Arnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383 · see citing works
Self-citation
Neuromodulation of Attention
Thiele, A., & Bellgrove, M. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.008 · Cited by 350 · see citing works
Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care
Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M. M., Miguel, Z. D., Ashford, J. W., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.008 · Cited by 224 · see citing works
Noradrenergic dysfunction in Alzheimer's disease
Gannon, M. A., Che, P., Chen, Y., Jiao, K., Roberson, E. D., & Wang, Q. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00220 · Cited by 211 · see citing works
The role of noradrenaline in cognition and cognitive disorders
Holland, N., Robbins, T. W., & Rowe, J. B. (2021) · Brain · doi:10.1093/brain/awab111 · Cited by 201 · see citing works
Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine
Cools, R., & Arnsten, A. F. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01100-8 · Cited by 206 · see citing works
Self-citation
The Potential for Misuse and Abuse of Medications in ADHD: A Review
Clemow, D. B., & Walker, D. J. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2801 · Cited by 198 · see citing works
Noradrenergic modulation of cognition: Therapeutic implications
Chamberlain, S. R., & Robbins, T. W. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113480988 · Cited by 193 · see citing works
Prefrontal and monoaminergic contributions to stop-signal task performance in rats
Bari, A., Mar, A. C., Theobald, D. E., Elands, S. A., Oganya, K. C. N. A., Eagle, D. M., & Robbins, T. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1543-11.2011 · Cited by 188 · see citing works
Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex
Yang, Y., Paspalas, C. D., Jin, L. E., Picciotto, M. R., Arnsten, A. F. T., & Wang, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307849110 · Cited by 188 · see citing works
Self-citation
Linking ADHD to the Neural Circuitry of Attention
Mueller, A., Hong, D. S., Shepard, S., & Moore, T. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.03.009 · Cited by 158 · see citing works
Decision Making: From Neuroscience to Psychiatry
Lee, D. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.008 · Cited by 169 · see citing works
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Spencer, R. C., Devilbiss, D. M., & Berridge, C. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.013 · Cited by 164 · see citing works
Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder
Berridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.023 · Cited by 160 · see citing works
Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery
Chamberlain, S. R., Robbins, T. W., Winder-Rhodes, S., Müller, U., Sahakian, B. J., Blackwell, A. D., & Barnett, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.019 · Cited by 178 · see citing works
Molecular modulation of prefrontal cortex: Rational development of treatments for psychiatric disorders.
Gamo, N. J., & Arnsten, A. F. T. (2011) · Behavioral Neuroscience · doi:10.1037/a0023165 · Cited by 124 · see citing works
Self-citation
Connecting the dots of the cerebro‐cerebellar role in cognitive function: Neuronal pathways for cerebellar modulation of dopamine release in the prefrontal cortex
Rogers, T. D., Dickson, P. E., Heck, D. H., Goldowitz, D., Mittleman, G., & Blaha, C. D. (2011) · Synapse · doi:10.1002/syn.20960 · Cited by 120 · see citing works
Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder
Schulz, K. P., Fan, J., Bédard, A.-C. V., Clerkin, S. M., Ivanov, I., Tang, C. Y., Halperin, J. M., & Newcorn, J. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2053 · Cited by 114 · see citing works
Differential cognitive actions of norepinephrine a2 and a1 receptor signaling in the prefrontal cortex
Berridge, C. W., & Spencer, R. C. (2016) · Brain Research · doi:10.1016/j.brainres.2015.11.024 · Cited by 112 · see citing works
COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review
Schacht, J. P. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.43 · Cited by 107 · see citing works
Psychostimulants and motivated behavior: Arousal and cognition
Berridge, C. W., & Arnsten, A. F. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.11.005 · Cited by 104 · see citing works
Self-citation
A behavioral neuroenergetics theory of ADHD
Killeen, P. R., Russell, V. A., & Sergeant, J. A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.011 · Cited by 97 · see citing works
Slow oscillating transcranial direct current stimulation during non-rapid eye movement sleep improves behavioral inhibition in attention-deficit/hyperactivity disorder
Munz, M. T., Prehn-Kristensen, A., Thielking, F., Mölle, M., Göder, R., & Baving, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00307 · Cited by 95 · see citing works
Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers
Marquand, A. F., Simoni, S. D., O’Daly, O., Williams, S., Mourão-Miranda, J., & Mehta, M. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.9 · Cited by 94 · see citing works
Striatal sensitivity during reward processing in attention-deficit/hyperactivity disorder
Paloyelis, Y., Mehta, M. A., Faraone, S. V., Asherson, P., & Kuntsi, J. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.05.006 · Cited by 94 · see citing works
Differential Sensitivity to Psychostimulants Across Prefrontal Cognitive Tasks: Differential Involvement of Noradrenergic α1- and α2-Receptors
Berridge, C. W., Shumsky, J. S., Andrzejewski, M. E., McGaughy, J. A., Spencer, R. C., Devilbiss, D. M., & Waterhouse, B. D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.022 · Cited by 94 · see citing works
Reorganization of Circuits Underlying Cerebellar Modulation of Prefrontal Cortical Dopamine in Mouse Models of Autism Spectrum Disorder
Rogers, T. D., Dickson, P. E., McKimm, E., Heck, D. H., Goldowitz, D., Blaha, C. D., & Mittleman, G. (2013) · The Cerebellum · doi:10.1007/s12311-013-0462-2 · Cited by 89 · see citing works
Atomoxetine modulates spontaneous and sensory-evoked discharge of Locus coeruleus noradrenergic neurons
Bari, A., & Aston-Jones, G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.020 · Cited by 85 · see citing works
The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics
Boswell, R. G., Potenza, M. N., & Grilo, C. M. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.10.014 · Cited by 82 · see citing works
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Jaeschke, R. R., Sujkowska, E., & Sowa-Kućma, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05946-0 · Cited by 90 · see citing works
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder
Arnsten, A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.133 · Cited by 80 · see citing works
Self-citation
The Modulation of Neural Noise Underlies the Effectiveness of Methylphenidate Treatment in Attention-Deficit/Hyperactivity Disorder
Pertermann, M., Bluschke, A., Roessner, V., & Beste, C. (2019) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.03.011 · Cited by 80 · see citing works
On the pathophysiology and treatment of akinetic mutism
Arnts, H., van Erp, W. S., Lavrijsen, J. C. M., van Gaal, S., Groenewegen, H. J., & van den Munckhof, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.006 · Cited by 79 · see citing works
Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks
Robinson, E. S. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2420-3 · Cited by 80 · see citing works
Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing
Orlando, I. F., Shine, J. M., Robbins, T. W., Rowe, J. B., & O’Callaghan, C. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105167 · Cited by 77 · see citing works
Prefrontal modulation of anxiety through a lens of noradrenergic signaling
Bouras, N., Mack, N. R., & Gao, W. (2023) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2023.1173326 · Cited by 72 · see citing works
Psychostimulants Act Within the Prefrontal Cortex to Improve Cognitive Function
Spencer, R. C., Klein, R. M., & Berridge, C. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.002 · Cited by 74 · see citing works
Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients
Clemow, D. B., & Bushe, C. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115602489 · Cited by 74 · see citing works
Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory
Cubillo, A., Smith, A. B., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., & Rubia, K. (2014) · Psychological Medicine · doi:10.1017/s0033291713000676 · Cited by 88 · see citing works
In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study
Yokokura, M., Takebasashi, K., Takao, A., Nakaizumi, K., Yoshikawa, E., Futatsubashi, M., Suzuki, K., Nakamura, K., Yamasue, H., & Ouchi, Y. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0784-7 · Cited by 66 · see citing works
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention‐deficit/hyperactivity disorder
Bedard, A., Stein, M. A., Halperin, J. M., Krone, B., Rajwan, E., & Newcorn, J. H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12272 · Cited by 62 · see citing works
The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography
Vanicek, T., Spies, M., Rami-Mark, C., Savli, M., Höflich, A., Kranz, G. S., Hahn, A., Kutzelnigg, A., Traub-Weidinger, T., Mitterhauser, M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1226 · Cited by 61 · see citing works
Neurochemistry of Visual Attention
Lockhofen, D. E. L., & Mulert, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.643597 · Cited by 62 · see citing works
Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid‐induced autism
Hara, Y., Ago, Y., Taruta, A., Katashiba, K., Hasebe, S., Takano, E., Onaka, Y., Hashimoto, H., Matsuda, T., & Takuma, K. (2015) · Autism Research · doi:10.1002/aur.1596 · Cited by 60 · see citing works
Atomoxetine facilitates attentional set shifting in adolescent rats
Cain, R. E., Wasserman, M. C., Waterhouse, B. D., & McGaughy, J. A. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.04.003 · Cited by 55 · see citing works
The Aversive Lens: Stress effects on the prefrontal-cingulate cortical pathways that regulate emotion
Arnsten, A. F. T., Joyce, M. K. P., & Roberts, A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.105000 · Cited by 58 · see citing works
Self-citation
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
Huß, M., Chen, W., & Ludolph, A. G. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0336-0 · Cited by 56 · see citing works
mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions
Jin, L. E., Wang, M., Yang, S.-T., Yang, Y., Galvin, V. C., Lightbourne, T. C., Ottenheimer, D. J., Zhong, Q., Stein, J., Raja, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.129 · Cited by 57 · see citing works
Self-citation
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
Busardò, F., Kyriakou, C., Cipolloni, L., Zaami, S., & Frati, P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150407225902 · Cited by 52 · see citing works
Methylphenidate as a cognitive enhancer in healthy young people
Batistela, S., Bueno, O. F. A., Vaz, L. J., & Galduróz, J. C. F. (2016) · Dementia & Neuropsychologia · doi:10.1590/s1980-5764-2016dn1002009 · Cited by 53 · see citing works
Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey
Kodama, T., Kojima, T., Honda, Y., Hosokawa, T., Tsutsui, K., & Watanabe, M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2155-16.2017 · Cited by 52 · see citing works
How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition
Hawk, L. W., Fosco, W. D., Colder, C. R., Waxmonsky, J. G., Pelham, W. E., & Rosch, K. S. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12917 · Cited by 51 · see citing works
Noradrenergic modulation of risk/reward decision making
Montes, D. R., Stopper, C. M., & Floresco, S. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3904-3 · Cited by 50 · see citing works
The Development of the Mesoprefrontal Dopaminergic System in Health and Disease
Islam, K. U. S., Meli, N., & Blaess, S. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.746582 · Cited by 50 · see citing works
Boosting Norepinephrine Transmission Triggers Flexible Reconfiguration of Brain Networks at Rest
Guedj, C., Monfardini, E., Reynaud, A. J., Farnè, A., Meunier, M., & Hadj‐Bouziane, F. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw262 · Cited by 50 · see citing works
Misuse of Methylphenidate
Clemow, D. B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_426 · Cited by 50 · see citing works
Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder
Shang, C., Yan, C., Lin, H., Tseng, W. I., Castellanos, F. X., & Gau, S. S. (2016) · Psychological Medicine · doi:10.1017/s0033291716001938 · Cited by 48 · see citing works
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
Kim, S., Bobeica, I., Gamo, N. J., Arnsten, A. F. T., & Lee, D. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2520-0 · Cited by 47 · see citing works
Self-citation
On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists
Pattij, T., Schetters, D., Schoffelmeer, A. N. M., & van Gaalen, M. M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2405-2 · Cited by 46 · see citing works
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
van Dyck, C. H., Arnsten, A. F. T., Padala, P. R., Brawman‐Mintzer, O., Lerner, A. J., Porsteinsson, A. P., Scherer, R. W., Levey, A. I., Herrmann, N., Jamil, N., et al. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.04.026 · Cited by 49 · see citing works
Self-citation
Neurocircuitry Underlying the Preferential Sensitivity of Prefrontal Catecholamines to Low-Dose Psychostimulants
Schmeichel, B. E., & Berridge, C. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.6 · Cited by 45 · see citing works
Divergent Whole Brain Projections from the Ventral Midbrain in Macaques
Zubair, M., Murris, S. R., Isa, K., Onoe, H., Koshimizu, Y., Kobayashi, K., Vanduffel, W., & Isa, T. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhaa399 · Cited by 43 · see citing works
The role of the locus coeruleus in shaping adaptive cortical melodies
Wainstein, G., Müller, E. J., Taylor, N. L., Munn, B., & Shine, J. M. (2022) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.03.006 · Cited by 45 · see citing works
Binding of Dopamine D1 Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study
Kubota, M., Fujino, J., Tei, S., Takahata, K., Matsuoka, K., Tagai, K., Sano, Y., Yamamoto, Y., Shimada, H., Takado, Y., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa211 · Cited by 43 · see citing works
Improved prefrontal activity in AD/HD children treated with atomoxetine: A NIRS study
Araki, A., Ikegami, M., Okayama, A., Matsumoto, N., Takahashi, S., Azuma, H., & Takahashi, M. (2014) · Brain and Development · doi:10.1016/j.braindev.2014.03.011 · Cited by 40 · see citing works
Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors
Miceli, M. D., & Gronier, B. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3849-y · Cited by 38 · see citing works
A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: Potential relevance to attention deficit hyperactivity disorder
Schmeichel, B. E., Zemlan, F. P., & Berridge, C. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.005 · Cited by 39 · see citing works
Adolescent Atomoxetine Treatment in a Rodent Model of ADHD: Effects on Cocaine Self-Administration and Dopamine Transporters in Frontostriatal Regions
Somkuwar, S. S., Jordan, C. J., Kantak, K. M., & Dwoskin, L. P. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.163 · Cited by 39 · see citing works
ADHD symptoms map onto noise-driven structure–function decoupling between hub and peripheral brain regions
Hearne, L. J., Lin, H., Sanz‐Leon, P., Tseng, W. I., Gau, S. S., Roberts, J. A., & Cocchi, L. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0554-6 · Cited by 38 · see citing works
Monoaminergic modulation of behavioural and electrophysiological indices of error processing
Barnes, J. J. M., O’Connell, R. G., Nandam, L. S., Dean, A. J., & Bellgrove, M. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3246-y · Cited by 38 · see citing works
Characterization of the hypothermic effects of imidazoline I2receptor agonists in rats
Thorn, D. A., An, X., Zhang, Y., Pigini, M., & Li, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01894.x · Cited by 38 · see citing works
Effects of serotonin–norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats
Umehara, M., Ago, Y., Fujita, K., Hiramatsu, N., Takuma, K., & Matsuda, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.033 · Cited by 37 · see citing works
Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control
Schulz, K. P., Clerkin, S. M., Fan, J., Halperin, J. M., & Newcorn, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2893-8 · Cited by 35 · see citing works
Magnesium supplementation in children with attention deficit hyperactivity disorder
Baza, F. E., Alshahawy, H. H., Zahra, S. S., & AbdelHakim, R. A. (2015) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2015.05.008 · Cited by 35 · see citing works
In for a Penny, in for a Pound: Methylphenidate Reduces the Inhibitory Effect of High Stakes on Persistent Risky Choice
Campbell-Meiklejohn, D. K., Simonsen, A., Scheel‐Krüger, J., Wohlert, V., Gjerløff, T., Frith, C., Rogers, R. D., Roepstorff, A., & Møller, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0151-12.2012 · Cited by 35 · see citing works
Methylphenidate Enhances NMDA-Receptor Response in Medial Prefrontal Cortex via Sigma-1 Receptor: A Novel Mechanism for Methylphenidate Action
Zhang, C.-L., Feng, Z.-J., Liu, Y., Ji, X.-H., Peng, J.-Y., Zhang, X.-H., Zhen, X.-C., & Li, B.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051910 · Cited by 41 · see citing works
PharmGKB summary
Stevens, T., Sangkuhl, K., Brown, J. T., Altman, R. B., & Klein, T. E. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000376 · Cited by 34 · see citing works
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
Minzenberg, M. J. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0128-7 · Cited by 41 · see citing works
MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs
Mar, A. C., Nilsson, S. R. O., Gamallo‐Lana, B., Lei, M., Dourado, T., Alsiö, J., Saksida, L. M., Bussey, T. J., & Robbins, T. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4679-5 · Cited by 33 · see citing works
Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates
Birn, R. M., Converse, A. K., Rajala, A. Z., Alexander, A. L., Block, W. F., McMillan, A. B., Christian, B. T., Filla, C., Murali, D., Hurley, S. A., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2513-18.2018 · Cited by 33 · see citing works
Thyrotoropin receptor knockout changes monoaminergic neuronal system and produces methylphenidate-sensitive emotional and cognitive dysfunction.
Mouri, A., Hoshino, Y., Narusawa, S., Ikegami, K., Mizoguchi, H., Murata, Y., Yoshimura, T., & Nabeshima, T. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.05.021 · Cited by 26 · see citing works
Muscarinic Attenuation of Mnemonic Rule Representation in Macaque Dorsolateral Prefrontal Cortex during a Pro- and Anti-Saccade Task
Major, A. J., Vijayraghavan, S., & Everling, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2454-15.2015 · Cited by 32 · see citing works
Background, clinical features and treatment of attention deficit hyperactivity disorder in children
Warikoo, N., & Faraone, S. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.818977 · Cited by 34 · see citing works
Stimulants for the Control of Hedonic Appetite
Poulton, A. S., Hibbert, E., Champion, B. L., & Nanan, R. K. H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00105 · Cited by 30 · see citing works
Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants
Spencer, R. C., & Berridge, C. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0314-y · Cited by 29 · see citing works
Effects of methylphenidate on the aggressive behavior, serotonin and dopamine levels, and dopamine-related gene transcription in brain of male Nile tilapia (Oreochromis niloticus)
Batalhão, I. G., Lima, D., Russi, A. P. M., Boscolo, C. N. P., da Silva, D. G. H., Pereira, T. S. B., Bainy, A. C. D., & de Almeida, E. A. (2019) · Fish Physiology and Biochemistry · doi:10.1007/s10695-019-00645-2 · Cited by 30 · see citing works
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Radonjić, N. V. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_33-1 · Cited by 31 · see citing works
Executive Function in Adults With Attention-Deficit/Hyperactivity Disorder During Treatment With Atomoxetine in a Randomized, Placebo-Controlled, Withdrawal Study
Adler, L. A., Tanaka, Y., Williams, D. W., Trzepacz, P. T., Goto, T., Allen, A. J., Escobar, R., & Upadhyaya, H. P. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000138 · Cited by 29 · see citing works
Noradrenaline transporter blockade increases fronto-parietal functional connectivity relevant for working memory
Hernaus, D., Santa, M. M. C., Offermann, J. S., & van Amelsvoort, T. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.02.004 · Cited by 29 · see citing works
Atomoxetine improves attentional orienting in a predictive context
Reynaud, A. J., Froesel, M., Guedj, C., Hassen, S. B. H., Cléry, J. C., Meunier, M., Hamed, S. B., & Hadj‐Bouziane, F. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.012 · Cited by 29 · see citing works
Noradrenergic contributions to cue-driven risk-taking and impulsivity
Chernoff, C. S., Hynes, T. J., & Winstanley, C. A. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05806-x · Cited by 30 · see citing works
Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder
Kawaura, K., Karasawa, J.-I., Chaki, S., & Hikichi, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.044 · Cited by 29 · see citing works
Animal Paradigms to Assess Cognition with Translation to Humans
Wallace, T. L., Ballard, T. M., & Glavis-Bloom, C. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-16522-6_2 · Cited by 26 · see citing works
Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks
Nandam, L. S., Hester, R., & Bellgrove, M. A. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.01.023 · Cited by 27 · see citing works
A novel approach to intra-individual performance variability in ADHD
Bluschke, A., Zink, N., Mückschel, M., Roessner, V., & Beste, C. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01555-y · Cited by 26 · see citing works
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26 · see citing works

P.1.g.032 Metabolic effects of lisdexamfetamine in a rat model of human obesity with insulin resistance
Heal, D. J., Vickers, S. P., Hackett, D., & Hutson, P. H. (2013) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(13)70319-5 · Cited by 4 · see citing works
Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363 · see citing works
Self-citation
In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: Involvement of dopamine D1 and alpha 2 adrenergic receptors
Gronier, B. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.002 · Cited by 44 · see citing works
Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors
Miceli, M. D., & Gronier, B. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3849-y · Cited by 38 · see citing works
Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder
Arnsten, A., & Dudley, A. G. (2005)
Self-citation

Authors: Gamo, N. J., Wang, M., & Arnsten, A. F. T.
Affiliations: Yale University (US)
ORCID: Gamo, Nao J.
Wang, Min
Arnsten, Amy F.T.
Venue: Journal of the American Academy of Child & Adolescent Psychiatry
Publisher: Elsevier BV
Published: 2010-10
Volume: 49
Issue: 10
Pages: 1011-1023
ISSN: 0890-8567 (ISSN-L)
DOI: 10.1016/j.jaac.2010.06.015
PMC: PMC2999884
OpenAlex: W2106437517
Cited by: 232
References: 68
Citations by year: 2026: 3 · 2025: 8 · 2024: 10 · 2023: 14 · 2022: 12 · 2021: 16 · 2020: 15 · 2019: 14 · 2018: 7 · 2017: 10 · 2016: 18 · 2015: 22 · 2014: 15 · 2013: 27 · 2012: 20
FWCI: 14.61
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (F31MH082548)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: methylphenidate, atomoxetine, attention deficit hyperactivity disorder, prefrontal cortex, alpha2-adrenoceptors, dopamine D1 receptor, working memory, idazoxan, SCH 23390, yohimbine, neuronal firing, dose-response relationship
MeSH terms: Atomoxetine Hydrochloride, Central Nervous System Stimulants, Animals, Appetitive Behavior, Attention Deficit Disorder with Hyperactivity, Brain Mapping, Child, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Humans, Macaca mulatta, Male, Memory, Short-Term, Methylphenidate, Nerve Net, Orientation, Propylamines, Saccades, Prefrontal Cortex, Receptors, Dopamine D1, Pyramidal Cells, Receptors, Adrenergic, alpha-2, Adrenergic Uptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks